BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21757001)

  • 1. Abnormal elevated PTEN expression in the mouse antrum of a model of GIST Kit(K641E/K641E).
    Deneubourg L; Ralea S; Gromova P; Parsons R; Vanderwinden JM; Erneux C
    Cell Signal; 2011 Nov; 23(11):1857-68. PubMed ID: 21757001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ENDOGLIN/CD105 is expressed in KIT positive cells in the gut and in gastrointestinal stromal tumours.
    Gromova P; Rubin BP; Thys A; Cullus P; Erneux C; Vanderwinden JM
    J Cell Mol Med; 2012 Feb; 16(2):306-17. PubMed ID: 21435173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in signaling pathways and expression level of the phosphoinositide phosphatase SHIP1 between two oncogenic mutants of the receptor tyrosine kinase KIT.
    Vanderwinden JM; Wang D; Paternotte N; Mignon S; Isozaki K; Erneux C
    Cell Signal; 2006 May; 18(5):661-9. PubMed ID: 15990278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
    Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
    Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E.
    Rubin BP; Antonescu CR; Scott-Browne JP; Comstock ML; Gu Y; Tanas MR; Ware CB; Woodell J
    Cancer Res; 2005 Aug; 65(15):6631-9. PubMed ID: 16061643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
    Mokhtari D; Al-Amin A; Turpaev K; Li T; Idevall-Hagren O; Li J; Wuttke A; Fred RG; Ravassard P; Scharfmann R; Tengholm A; Welsh N
    Diabetologia; 2013 Jun; 56(6):1327-38. PubMed ID: 23462796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoinositide 3-kinase inhibitors combined with imatinib in patient-derived xenograft models of gastrointestinal stromal tumors: rationale and efficacy.
    Van Looy T; Wozniak A; Floris G; Sciot R; Li H; Wellens J; Vanleeuw U; Fletcher JA; Manley PW; Debiec-Rychter M; Schöffski P
    Clin Cancer Res; 2014 Dec; 20(23):6071-82. PubMed ID: 25316817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kitlow stem cells cause resistance to Kit/platelet-derived growth factor alpha inhibitors in murine gastrointestinal stromal tumors.
    Bardsley MR; Horváth VJ; Asuzu DT; Lorincz A; Redelman D; Hayashi Y; Popko LN; Young DL; Lomberk GA; Urrutia RA; Farrugia G; Rubin BP; Ordog T
    Gastroenterology; 2010 Sep; 139(3):942-52. PubMed ID: 20621681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor.
    Rossi F; Ehlers I; Agosti V; Socci ND; Viale A; Sommer G; Yozgat Y; Manova K; Antonescu CR; Besmer P
    Proc Natl Acad Sci U S A; 2006 Aug; 103(34):12843-8. PubMed ID: 16908864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylate.
    Liu Y; Tseng M; Perdreau SA; Rossi F; Antonescu C; Besmer P; Fletcher JA; Duensing S; Duensing A
    Cancer Res; 2007 Mar; 67(6):2685-92. PubMed ID: 17363589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kit K641E oncogene up-regulates Sprouty homolog 4 and trophoblast glycoprotein in interstitial cells of Cajal in a murine model of gastrointestinal stromal tumours.
    Gromova P; Ralea S; Lefort A; Libert F; Rubin BP; Erneux C; Vanderwinden JM
    J Cell Mol Med; 2009 Aug; 13(8A):1536-48. PubMed ID: 19453770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin receptor 1 is expressed in gastrointestinal stromal tumors but not in interstitial cells of Cajal.
    Gromova P; Rubin BP; Thys A; Erneux C; Vanderwinden JM
    PLoS One; 2011 Feb; 6(2):e14710. PubMed ID: 21364741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of imatinib vary with the types of KIT-mutation in gastrointestinal stromal tumor cell lines.
    Noma K; Naomoto Y; Gunduz M; Matsuoka J; Yamatsuji T; Shirakawa Y; Nobuhisa T; Okawa T; Takaoka M; Tomono Y; Hiroyuki O; Gunduz E; Tanaka N
    Oncol Rep; 2005 Sep; 14(3):645-50. PubMed ID: 16077968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumors.
    Quattrone A; Wozniak A; Dewaele B; Floris G; Vanspauwen V; Van Looy T; Schöffski P; Rutkowski P; Sciot R; Debiec-Rychter M
    Mod Pathol; 2014 Nov; 27(11):1510-20. PubMed ID: 24743220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo effect of imatinib on progression of cecal GIST-like tumors in exon 17-type c-kit knock-in mice.
    Ishikawa T; Nakai N; Liu NN; Shiba K; Isozaki K; Matsuda I; Ito T; Fujimoto J; Hatakeyama K; Kanda T; Hirota S
    Lab Invest; 2009 Oct; 89(10):1161-8. PubMed ID: 19636292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours.
    Chi P; Chen Y; Zhang L; Guo X; Wongvipat J; Shamu T; Fletcher JA; Dewell S; Maki RG; Zheng D; Antonescu CR; Allis CD; Sawyers CL
    Nature; 2010 Oct; 467(7317):849-53. PubMed ID: 20927104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors.
    Simon S; Grabellus F; Ferrera L; Galietta L; Schwindenhammer B; Mühlenberg T; Taeger G; Eilers G; Treckmann J; Breitenbuecher F; Schuler M; Taguchi T; Fletcher JA; Bauer S
    Cancer Res; 2013 Jun; 73(12):3661-70. PubMed ID: 23576565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.
    Artemenko Y; Gagnon A; Sorisky A
    J Cell Physiol; 2009 Jan; 218(1):228-36. PubMed ID: 18814181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct engagement of the PI3K pathway by mutant KIT dominates oncogenic signaling in gastrointestinal stromal tumor.
    Bosbach B; Rossi F; Yozgat Y; Loo J; Zhang JQ; Berrozpe G; Warpinski K; Ehlers I; Veach D; Kwok A; Manova K; Antonescu CR; DeMatteo RP; Besmer P
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8448-E8457. PubMed ID: 28923937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines.
    Sharrard RM; Maitland NJ
    Cell Signal; 2007 Jan; 19(1):129-38. PubMed ID: 16842970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.